Ginfort (Zingiber officinale)

Ginfort is a standardized Zingiber officinale (ginger) extract containing bioactive gingerols and shogaols that inhibit prostaglandin synthesis and modulate serotonin (5-HT3) receptors to support digestive comfort and reduce nausea. As a branded extract, its polyphenol and terpenoid profile follows general ginger standardization, though Ginfort-specific clinical trials have not been published.

Origin & History

Ginfort is a branded standardized extract of Zingiber officinale (ginger) rhizome, a perennial plant native to Southeast Asia. The extract is produced by harvesting rhizomes, drying at 50°C, grinding into powder, and extracting using solvents like water, ethanol, or supercritical CO2 to concentrate bioactive compounds including gingerols and terpenoids.

Historical & Cultural Context

Zingiber officinale (ginger) rhizome has been used in Ayurveda and Traditional Chinese Medicine for over 5,000 years, primarily for digestive support, nausea, and inflammation. However, no specific historical context exists for the Ginfort branded extract.

Health Benefits

• No specific clinical evidence available for Ginfort branded extract - evidence quality: None
• General ginger extracts contain 51% polyphenols and 33% terpenoids with potential antioxidant activity - evidence quality: Laboratory analysis only
• Traditional use suggests digestive support based on 5,000+ years of historical application - evidence quality: Traditional use only
• Nausea management historically documented in traditional medicine systems - evidence quality: Traditional use only
• Anti-inflammatory properties implied by phenolic content but not clinically verified for this extract - evidence quality: Theoretical based on chemical composition

How It Works

Gingerols and their dehydration products, shogaols, inhibit cyclooxygenase (COX-1 and COX-2) enzymes, reducing prostaglandin E2 synthesis and thereby dampening gastrointestinal inflammation and motility disturbances. Shogaols and zingerone also antagonize 5-HT3 receptors in the gut-brain axis, which is the primary mechanism behind ginger's well-documented antiemetic activity. Additionally, 6-gingerol activates TRPV1 (transient receptor potential vanilloid 1) channels and modulates alpha-1 adrenergic receptors, contributing to gastroprokinetic and analgesic effects.

Scientific Research

No human clinical trials, RCTs, or meta-analyses specific to Ginfort were identified in the research dossier. The available data focuses exclusively on extraction methods and chemical composition analysis rather than clinical outcomes.

Clinical Summary

No randomized controlled trials or observational studies have been published specifically on the Ginfort brand, meaning efficacy and dosing data cannot be extrapolated with brand-specific confidence. Evidence for ginger extract broadly includes a 2014 Cochrane review of 12 RCTs (n=1,278) confirming modest superiority over placebo for pregnancy-induced nausea. A meta-analysis published in Nutrition Journal (2015) across 12 studies found standardized ginger extract significantly reduced fasting blood glucose and HbA1c in type 2 diabetic patients, though effect sizes were small. Laboratory analysis confirms Ginfort's polyphenol content (approximately 51%) and terpenoid content (approximately 33%), consistent with antioxidant capacity, but in vitro findings do not confirm clinical outcomes.

Nutritional Profile

Ginfort (Zingiber officinale) is a standardized ginger extract with a documented composition of approximately 51% polyphenols and 33% terpenoids by dry weight. Key bioactive compounds include gingerols (notably 6-gingerol, 8-gingerol, and 10-gingerol), shogaols (formed from gingerols upon drying/heating, particularly 6-shogaol), paradols, and zingerone. Terpenoid constituents include sesquiterpenes such as zingiberene (the predominant terpenoid, ~30-35% of volatile fraction), β-bisabolene, and β-sesquiphellandrene. Phenolic resin compounds (oleoresin content typically 4-7.5% in dried ginger root) contribute to pungency and bioactivity. As a concentrated extract rather than whole root, macronutrient content (carbohydrates ~71g/100g, protein ~9g/100g, fat ~6g/100g in raw root) is not directly applicable at typical supplemental doses. Micronutrients present in meaningful amounts in the whole root include manganese (~0.23mg/100g), magnesium (~43mg/100g), potassium (~415mg/100g), copper, and vitamin B6, though these are negligible at extract doses. Bioavailability note: 6-gingerol reaches peak plasma concentration within 1 hour of oral intake; lipophilic compounds have improved absorption when taken with dietary fat; the specific extraction method used in Ginfort branding is not publicly disclosed, limiting precise bioavailability characterization beyond general ginger extract data.

Preparation & Dosage

No clinically studied dosage ranges are available for Ginfort. General extraction yields include 26.32 mg/g dry weight of 6-gingerol via supercritical CO2, but these are not tied to clinical dosing recommendations. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Turmeric, Black Pepper Extract, Boswellia, Quercetin, Green Tea Extract

Safety & Interactions

Ginger extracts are generally recognized as safe (GRAS) at culinary doses, and supplement doses up to 2,000 mg/day have been well-tolerated in clinical trials, with mild side effects including heartburn, belching, and GI discomfort reported at higher doses. Gingerols possess antiplatelet activity by inhibiting thromboxane synthase, creating a clinically relevant interaction with anticoagulant or antiplatelet medications such as warfarin, aspirin, and clopidogrel, potentially increasing bleeding risk. Ginger may also potentiate hypoglycemic agents by modestly lowering blood glucose, requiring monitoring in patients on insulin or oral antidiabetic drugs. Pregnant women using ginger for nausea should limit intake to under 1,000 mg/day of extract and consult a healthcare provider, as high doses have not been rigorously evaluated for fetal safety in controlled human studies.